Home From Drew Altman

From Drew Altman

Drew Altman is president and chief executive officer of KFF, a position he has held for more than 30 years since founding the modern-day KFF organization in the 1990s. He is a leading expert on national health policy issues and an innovator in health journalism and the nonprofit field.

View full bio | Read Dr. Altman's Beyond the Data columns

Photo of Drew Altman

President’s Message

“KFF is an independent source of health policy research, polling, and journalism. We have four major program areas: KFF Policy; KFF Polling; KFF Health News (formerly Kaiser Health News); and KFF Social Impact Media, which conducts specialized public health information campaigns. Learn more about the organization. 

What’s unique about KFF, however, can’t be found in any description of our programs because we’re more than a sum of our parts. KFF is a one-of-a-kind information organization. Not a policy research organization. Not a polling organization. And not a news organization. But rather, a unique combination of all three. That’s the vision behind KFF, and it's this combination that allows us to leverage our combined expertise and assets to play our national role on health policy.” Read more

Beyond the Data

In his “Beyond the Data” columns, Drew Altman discusses what the data, polls, and journalism produced by KFF mean for policy and for people.

The Semi-Sad Prospects for Controlling Employer Health Care Costs

In a commentary on KFF’s 27th employer health benefits survey, President and CEO Dr. Drew Altman discusses the obstacles employers face trying to control their health care costs, and the reasons why they’ve never been meaningful supporters of government cost-containment efforts. He predicts that premium increases expected next year could lead to a new wave of higher deductibles and other forms of cost sharing for the 155 million Americans who rely on employer coverage. Read the column here.

View All Beyond the Data Columns

View the Latest: From Drew Altman

Filter

List Grid

261 - 270 of 327 Results

  • What to Expect From the Next Congress on the ACA

    From Drew Altman

    In this column for The Wall Street Journal’s Think Tank, Drew Altman explains how Republican control of Congress will likely bring challenges to the Affordable Care Act in two flavors.

  • How the Midterms Factor Into Medicaid Expansion

    From Drew Altman

    In this column for The Wall Street Journal’s Think Tank, Drew Altman discusses how Democratic victories in several close gubernatorial races on Tuesday could revive efforts to expand Medicaid.

  • The Benefit of a Uniform Response to Ebola in the U.S.

    From Drew Altman

    In this column for The Wall Street Journal’s Think Tank, Drew Altman discusses the Christie, Cuomo rift with the federal government over Ebola public health measures and the need for uniform national policies to ease the public’s fears.

  • Poll: Obamacare Is Not a Big Issue With Midterm Voters

    From Drew Altman

    In this column for The Wall Street Journal’s Think Tank, Drew Altman analyzes recent polling data on the Affordable Care Act and discusses why it will not be a significant factor in next week’s midterm election.

  • Poll: Most Americans Positive About Ebola Response

    From Drew Altman

    In this column for The Wall Street Journal’s Think Tank, Drew Altman looks at public confidence in the Centers for Disease Control and Prevention (CDC) amid the response to Ebola in the U.S. based on two Foundation polls taken over the past two weeks.

  • Shifting Views on Same-Sex Marriage, Marijuana and End-of-Life Issues

    From Drew Altman

    In this column for The Wall Street Journal’s Think Tank, Drew Altman examines three areas of American life where public attitudes have been steadily changing – same sex marriage, marijuana, and end of life issues – and discusses the implications for policy and law.

  • Challenges for the Next Obamacare Open Enrollment

    From Drew Altman

    In this column for The Wall Street Journal’s Think Tank, Drew Altman pinpoints the Affordable Care Act’s five biggest challenges heading into the second open enrollment period.